Ishiguro T, Naito M, Yamamoto T, Hasegawa G, Gejyo F, Mitsuyama M, Suzuki H, Kodama T
Second Department of Pathology and Second Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan.
Am J Pathol. 2001 Jan;158(1):179-88. doi: 10.1016/S0002-9440(10)63956-9.
Type I and type II macrophage scavenger receptors (SR-A I/II) recognize a variety of polyanions including bacterial cell-wall products such as lipopolysaccharide, suggesting a role for SR-A I/II in immunity against bacterial infection. SR-A I/II-deficient (MSR-A-/-) mice were more susceptible to infection with listeriolysin-O (LLO)-producing Listeria monocytogenes. After infection, Kupffer cells in wild-type (MSR-A+/+) mice phagocytized larger numbers of Listeria than those in MSR-A-/- mice. The number and the diameter of hepatic granulomas were larger in MSR-A-/- mice than MSR-A+/+ mice. L. monocytogenes replicated at higher levels in the liver of MSR-A-/- mice compared with MSR-A+/+ mice, and macrophages from MSR-A-/- mice showed impaired ability to kill Listeria in vitro. However, macrophages from MSR-A+/+ and MSR-A-/- mice showed similar levels of listericidal activity against isogenic mutant L. monocytogenes with an inactivated LLO gene. The listerial phagocytic activities of MSR-A+/+ macrophages treated with an anti-SR-A I/II antibody (2F8) and MSR-A-/- macrophages were significantly impaired compared with untreated MSR-A+/+ macrophages, indicating that SR-A I/II function as a receptor for L. monocytogenes. Electron microscopy revealed that most L. monocytogenes had been eliminated from the lysosomes of MSR-A+/+ macrophages in vivo and in vitro. In contrast, L. monocytogenes rapidly lysed the phagosomal membrane and escaped to the cytosol in MSR-A-/- macrophages and in MSR-A+/+ macrophages treated with 2F8 before phagosome-lysosome fusion. These findings imply that SR-A I/II plays a crucial role in host defense against listerial infection not only by functioning as a receptor but also by mediating listericidal mechanisms through the regulation of LLO-dependent listerial escape from the macrophages.
I型和II型巨噬细胞清道夫受体(SR-A I/II)可识别多种多阴离子,包括细菌细胞壁产物如脂多糖,这表明SR-A I/II在抗细菌感染免疫中发挥作用。缺乏SR-A I/II(MSR-A-/-)的小鼠对产李斯特菌溶血素-O(LLO)的单核细胞增生李斯特菌感染更易感。感染后,野生型(MSR-A+/+)小鼠的库普弗细胞吞噬的李斯特菌数量比MSR-A-/-小鼠的多。MSR-A-/-小鼠肝脏肉芽肿的数量和直径比MSR-A+/+小鼠的大。与MSR-A+/+小鼠相比,单核细胞增生李斯特菌在MSR-A-/-小鼠肝脏中的复制水平更高,且来自MSR-A-/-小鼠的巨噬细胞在体外杀灭李斯特菌的能力受损。然而,来自MSR-A+/+和MSR-A-/-小鼠的巨噬细胞对LLO基因失活的同基因单核细胞增生李斯特菌突变体显示出相似水平的杀李斯特菌活性。与未处理的MSR-A+/+巨噬细胞相比,用抗SR-A I/II抗体(2F8)处理的MSR-A+/+巨噬细胞和MSR-A-/-巨噬细胞的李斯特菌吞噬活性显著受损,表明SR-A I/II作为单核细胞增生李斯特菌的受体发挥作用。电子显微镜显示,在体内和体外,大多数单核细胞增生李斯特菌已从MSR-A+/+巨噬细胞的溶酶体中清除。相反,在吞噬体-溶酶体融合之前,单核细胞增生李斯特菌在MSR-A-/-巨噬细胞和用2F8处理的MSR-A+/+巨噬细胞中迅速裂解吞噬体膜并逃逸到细胞质中。这些发现表明,SR-A I/II在宿主抵御李斯特菌感染的防御中起关键作用,不仅作为受体发挥作用,还通过调节LLO依赖的李斯特菌从巨噬细胞中逃逸来介导杀李斯特菌机制。